SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/17/17 Creative Medical Tech Holdin… Inc 8-K:1,5,9 11/17/17 2:35K Toppan Vintage/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 16K 2: EX-99.1 Miscellaneous Exhibit HTML 13K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 17, 2017
Creative Medical Technology Holdings, Inc.
(Exact name of registrant as specified in its charter)
Nevada | 000-53500 | 87-0622284 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
2017 W Peoria Avenue, Phoenix, AZ 85029 |
(Address of principal executive offices) |
Registrant’s telephone number, including area code: (602) 680-7439
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01 | Entry into a Material Definitive Agreement. |
On November 17, 2017, Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), entered into a Management Reimbursement Agreement dated November 17, 2017 (the “Agreement”), with Creative Medical Technologies, Inc. (“CMT”), the wholly owned subsidiary of the Company, and with Creative Medical Health, Inc., the parent of the Company (“CMH”). The Agreement memorializes the arrangement between the parties whereby the Company has, since January 1, 2016, reimbursed CMH for the services of management and consultants employed by CMH and performing services for the Company and CMT. The following table sets forth the amounts of the monthly reimbursements:
Name | Reimbursement Amount | |||
Timothy Warbington | $ | 10,000 | ||
Thomas Ichim, PhD | $ | 5,000 | ||
Donald Dickerson | $ | 10,000 | ||
Annette Marleau | $ | 5,000 | ||
Dr. Amit Patel | $ | 5,000 | ||
TOTAL | $ | 35,000 |
At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price (as reported by OTC Markets or other principal trading platform or market for the Company’s common stock) during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice.
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
The information for this item is incorporated by reference to the disclosure contained in Item 1.01 above.
Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits.
Exhibit No. | Description | |
99.1 | Management Reimbursement Agreement dated November 17, 2017 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Creative Medical Technology Holdings, Inc. | ||
Date: November 17, 2017 | By: | /s/ Timothy Warbington |
Timothy Warbington, Chief Executive Officer |
3
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period End: | 11/17/17 | None on these Dates | ||
1/1/16 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/12/23 Creative Medical Tech Holdin… Inc 10-Q 3/31/23 45:2.6M Discount Edgar/FA 3/31/23 Creative Medical Tech Holdin… Inc 10-K 12/31/22 57:8M Discount Edgar/FA 4/22/22 Creative Medical Tech Holdin… Inc S-1 56:5.7M Discount Edgar/FA 3/30/22 Creative Medical Tech Holdin… Inc 10-K 12/31/21 58:5.2M Discount Edgar/FA 12/02/21 Creative Medical Tech Holdin… Inc S-1/A 60:7.5M Discount Edgar/FA 12/01/21 Creative Medical Tech Holdin… Inc S-1/A 63:7.8M Discount Edgar/FA 11/23/21 Creative Medical Tech Holdin… Inc S-1/A 65:8.1M Discount Edgar/FA 9/28/21 Creative Medical Tech Holdin… Inc S-1 9/27/21 64:6.2M Discount Edgar/FA 3/17/21 Creative Medical Tech Holdin… Inc 10-K 12/31/20 60:8.3M Discount Edgar/FA |